SCHEMBL4399427

SCHEMBL4399427

O=C1NCc2cc(-c3ccc(Nc4ccc(S(=O)(=O)NC5CCN(C(=O)O)C5)cc4)c4nccn34)ccc21

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPKAPK5 Q8IW41 3/20 0.45
GSK3B P49841 2/20 0.37
EIF4E P06730 1/20 0.34
MKNK1 Q9BUB5 1/20 0.34
MKNK2 Q9HBH9 1/20 0.34
GPR119 Q8TDV5 1/20 0.33
TARS1 P26639 1/20 0.33
F13A1 P00488 2/20 0.33
TGM2 P21980 2/20 0.33
TGM1 P22735 2/20 0.33
SYK P43405 2/20 0.32
TP53BP1 Q12888 1/20 0.32
UCHL1 P09936 4/20 0.32
USP30 Q70CQ3 4/20 0.32
LIPG Q9Y5X9 1/20 0.32
LRRK2 Q5S007 1/20 0.31
NAMPT P43490 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1685182 0.90 GPR119 (0.45) MAPKAPK5GSK3BGPR119USP30
SCHEMBL1685157 0.85 MAPKAPK5 (0.46) MAPKAPK5GSK3BEIF4EMKNK1MKNK2
SCHEMBL1685196 0.82 MAPKAPK5 (0.51) MAPKAPK5GSK3BMKNK1MKNK2TARS1
SCHEMBL1685332 0.80 MAPKAPK5 (0.51) MAPKAPK5GSK3BEIF4EMKNK1MKNK2
SCHEMBL10166873 0.80 MAPKAPK5 (0.53) MAPKAPK5GSK3BMKNK1TARS1
SCHEMBL10134756 0.80 MAPKAPK5 (0.53) MAPKAPK5GSK3BEIF4EMKNK1MKNK2
SCHEMBL1685321 0.80 MAPKAPK5 (0.53) MAPKAPK5GSK3BMKNK1MKNK2TARS1
SCHEMBL14162843 0.80 MAPKAPK5 (0.44) MAPKAPK5GSK3BSYK
SCHEMBL1685188 0.79 MAPKAPK5 (0.53) MAPKAPK5GSK3BEIF4EMKNK1MKNK2
SCHEMBL10133651 0.78 MAPKAPK5 (0.51) MAPKAPK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2099798-A1 IMIDAZOLOPYRIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES Galapagos N.V. (BE) 2009-09-16 EP disclosed
WO-2008065199-A1 IMIDAZOLOPYRIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES GALAPAGOS N.V. (BE) 2008-06-05 WO disclosed